
Sign up to save your podcasts
Or


With Moderna’s vaccine reporting an efficacy rate of 94.5% and the Dow hitting an all-time high of 30,000, is it time to change your investment plan?
The Morning Run also gets into US Treasuries, how RCEP will impact the US, and whether increased regulatory scrutiny in China is a concern for investors.
By BFM Media3.5
22 ratings
With Moderna’s vaccine reporting an efficacy rate of 94.5% and the Dow hitting an all-time high of 30,000, is it time to change your investment plan?
The Morning Run also gets into US Treasuries, how RCEP will impact the US, and whether increased regulatory scrutiny in China is a concern for investors.

3,228 Listeners

1,713 Listeners

977 Listeners

406 Listeners

1,993 Listeners

355 Listeners

3 Listeners

20 Listeners

686 Listeners

1,044 Listeners

684 Listeners

6,097 Listeners

2 Listeners

80 Listeners

9 Listeners